Name: Revefenacin - API Standards
Brand: Pharmaffliates
Rating: 4.50 (5 reviews)

Catalogue number:	PA 18 1230000
Chemical name:	Revefenacin
CAS Number:	864750-70-9
Category:	impurities,metabolites,pharmaceutical standards,intermediates,Fine Chemicals
Synonyms:	Carbamic acid, N-[1,1'-biphenyl]-2-yl-, 1-[2-[[4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]benzoyl]methylamino]ethyl]-4-piperidinyl ester; 1-[2-(1-{4-[(4-Carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1'-biphenyl]-2-yl}carbamate;
Molecular form:	C₃₅H₄₃N₅O₄
Appearance:	NA
Mol. Weight:	597.76
Storage:	2-8°C Refrigerator
Shipping Conditions:	Ambient
Applications:	Revefenacin is a novel biphenyl carbamate tertiary amine agent that belongs to the family of the long-acting muscarinic antagonists (LABA). The labile primary amide in the structure produces a "soft-drug" site that allows rapid systemic clearance and minimizing of the systemically mediated adverse reactions. The LABA group falls into a parent category known as long-acting inhaled bronchodilators and this type of agents are recommended as a maintenance therapy for chronic obstructive pulmonary disease (COPD).1 From the LABA group, revefenacin is the first once-daily nebulized LAMA treatment.2 It was developed by Theravance Biopharma and FDA approved on November 9, 2018.8

Enquire for Revefenacin - API Standards

Revefenacin - API Standards

CAS Number: